Report overview
Meniere?s disease is a disorder of middle ear that causes vertigo, ringing sound in the ear and hearing problems. In most of the cases this disease only affects one ear. Meniere?s disease can affect anyone but the prevalence is on a higher side in people aged from 20-50. This is a chronic disease but different treatments can help in minimizing the symptoms.
This report contains market size and forecasts of Meniere's Disease Drugs in Global, including the following market information:
Global Meniere's Disease Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Meniere's Disease Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Motion Sickness Medication Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Meniere's Disease Drugs include Roche, Novartis, Pfizer, Auris Medical, Jubilant Cadista, Otonomy, Sound Pharmaceuticals and WellSpring Pharmaceutical, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Meniere's Disease Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Meniere's Disease Drugs Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Meniere's Disease Drugs Market Segment Percentages, by Type, 2021 (%)
Motion Sickness Medication
Anti-Nausea Medication
Others
Global Meniere's Disease Drugs Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Meniere's Disease Drugs Market Segment Percentages, by Application, 2021 (%)
Hospitals
Clinics
Medical Research Centers
Others
Global Meniere's Disease Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Meniere's Disease Drugs Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Meniere's Disease Drugs revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Meniere's Disease Drugs revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Roche
Novartis
Pfizer
Auris Medical
Jubilant Cadista
Otonomy
Sound Pharmaceuticals
WellSpring Pharmaceutical
